论文部分内容阅读
根据女用长效口服避孕药全国协作计划,为了了解长期应用甾体激素口服避孕药在遗传方面的安全性问题,我们对服用复方18甲基炔诺酮长效口服避孕药(以下简称复方18甲)减量和全量的育龄妇女进行了外周血淋巴细胞染色体畸变率的观察。1978年对拟服用减量药的61例纺织女工进行服药前检查,且已就其中50例健康者的染色体畸变分析结果作了总结。1979年5月以后对有自身对照之服用减量复方18甲之妇
According to the National Long-term Oral Contraceptives for Women Program, in order to understand the genetic safety of long-term use of oral contraceptive steroid hormones, we took 18 long-acting oral contraceptives (hereinafter referred to as Compound 18 A) Reduction and full-scale women of childbearing age were observed peripheral blood lymphocyte chromosome aberration rate. In 1978, 61 women textile workers who were taking weight-reducing drugs were examined before taking the medication, and the results of chromosome aberration analysis of 50 healthy people were summarized. After 1979 May have their own control of the reduction of 18 women take a reduction compound